Form D · Venture Capital Fund
GJG Life Sciences, LLC
Staten Island, NY · CIK 0001582638
Offering snapshot reported Aug 6, 2013 · SEC filing
- Reported sold
- $1.8M Offering amount: $5M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 24, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2013 | Initial | $1,804,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-200860
If the maximum offering amount is sold, the Issuer may sell up to an additional $2,500,000.
Source: Form D, filed Aug 6, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jennifer A. Lorenzo | Executive |
| Gregg Lorenzo | Executive, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
80 Bay Street Landing Apt. 3 F
Staten Island, NY, 10301
Staten Island, NY, 10301